Cargando…

Efficacy of epicutaneous immunotherapy (EPIT) in a new model of peanut-induced eosinophilic esophagitis (EoE) and allergic enterpathy (AE)

Detalles Bibliográficos
Autores principales:	Mondulet, Lucie, Dioszeghy, Vincent, Dhelft, Véronique, Ligouis, Mélanie, Puteaux, Emilie, Larcher, Thibaut, Cherel, Yan, Dupont, Christophe, Benhamou, Pierre-Henri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354110/ http://dx.doi.org/10.1186/2045-7022-1-S1-O50

Ejemplares similares

Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice
por: Mondoulet, Lucie, et al.
Publicado: (2012)

Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice
por: Mondoulet, Lucie, et al.
Publicado: (2012)

The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice
por: Dioszeghy, V, et al.
Publicado: (2014)

Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut
por: Dioszeghy, Vincent, et al.
Publicado: (2017)

Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense)
por: Mondoulet, Lucie, et al.
Publicado: (2012)

Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut‐sensitized mice
por: Mondoulet, L., et al.
Publicado: (2018)

Predicted number of peanut‐allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
por: Remington, Benjamin C., et al.
Publicado: (2021)

3-months elimination diet in childhood EoE: nutritional and immunological aspects
por: Colson, D, et al.
Publicado: (2013)

Role of Vasoactive Intestinal Peptide in Promoting the Pathogenesis of Eosinophilic Esophagitis (EoE)
por: Verma, Alok K., et al.
Publicado: (2017)

Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice
por: Dioszeghy, Vincent, et al.
Publicado: (2018)

Altered Esophageal Histamine Receptor Expression in Eosinophilic Esophagitis (EoE): Implications on Disease Pathogenesis
por: Merves, Jamie, et al.
Publicado: (2015)

Systematic review of outcome measures in randomised controlled trials of pediatric eosinophilic esophagitis (EoE) treatment
por: Rubin, Tamar, et al.
Publicado: (2014)

Topical Steroid Therapy for the Treatment of Eosinophilic Esophagitis (EoE): A Systematic Review and Meta-Analysis
por: Chuang, Ming-yu (Anthony), et al.
Publicado: (2015)

Eosinophilic Esophagitis in Children and Adolescents with Abdominal Pain: Comparison with EoE-Dysphagia and Functional Abdominal Pain
por: Gunasekaran, Thirumazhisai, et al.
Publicado: (2016)

Eosinophilic esophagitis (EoE); a disease that must not be neglected - implications of esophageal rupture and its management
por: Larsson, Helen, et al.
Publicado: (2020)

Assessment of local and systemic signature of eosinophilic esophagitis (EoE) in children through multi-omics approaches
por: Adel-Patient, Karine, et al.
Publicado: (2023)

Triclosan promotes epicutaneous sensitization to peanut in mice
por: Tobar, Steven, et al.
Publicado: (2016)

Transitioning from epicutaneous to oral peanut immunotherapy
por: Wong, Lauren, et al.
Publicado: (2023)

Epicutaneous immunotherapy protects cashew‐sensitized mice from anaphylaxis
por: Pelletier, Benjamin, et al.
Publicado: (2020)

EoE behaves as a unique Th2 disease: a narrative review
por: Rabinowitz, Simon S., et al.
Publicado: (2023)

Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry
por: Navarro, Pilar, et al.
Publicado: (2022)

Genetics of eosinophilic esophagitis (EOE)
por: Cianferoni, Antonella
Publicado: (2011)

Early Life Risk Factors in Pediatric EoE: Could We Prevent This Modern Disease?
por: Votto, Martina, et al.
Publicado: (2020)

Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE)
por: Chandramouleeswaran, Prasanna M., et al.
Publicado: (2016)

Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities
por: Davis, Carla M., et al.
Publicado: (2022)

Review of Non-Eosinophilic Esophagitis-Eosinophilic Gastrointestinal Disease (Non-EoE-EGID) and a Case Series of Twenty-Eight Affected Patients
por: Kinoshita, Yoshikazu, et al.
Publicado: (2023)

Recent advances in epicutaneous immunotherapy and potential applications in food allergy
por: Hervé, Pierre-Louis, et al.
Publicado: (2023)

EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe
por: Lucendo, Alfredo J., et al.
Publicado: (2022)

Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapy
por: Bégin, Philippe, et al.
Publicado: (2021)

Prevalence of HCV genotypes in Poland – the EpiTer study
por: Flisiak, Robert, et al.
Publicado: (2016)

Accidental exposure (AE) to peanut in a large cohort of Canadian children with peanut allergy
por: Cherkaoui, Sabrine, et al.
Publicado: (2014)

Plasma levels of TNF-α, IL-6, IFN-γ, IL-12, IL-17, IL-22, and IL-23 in achalasia, eosinophilic esophagitis (EoE), and gastroesophageal reflux disease (GERD)
por: Clayton, Steven, et al.
Publicado: (2019)

Efficacy of HCV treatment in Poland at the turn of the interferon era – the EpiTer study
por: Flisiak, Robert, et al.
Publicado: (2016)

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study
por: Rajewski, Paweł, et al.
Publicado: (2022)

Pre-Existing Humoral Immunity Enhances Epicutaneously-Administered Allergen Capture by Skin DC and Their Migration to Local Lymph Nodes
por: Hervé, Pierre-Louis, et al.
Publicado: (2021)

Development of [(131)I]I-EOE-TPZ and [(131)I]I-EOE-TPZMO: Novel Tirapazamine (TPZ)-Based Radioiodinated Pharmaceuticals for Application in Theranostic Management of Hypoxia
por: Elsaidi, Hassan, et al.
Publicado: (2019)

Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
por: Senti, Gabriela, et al.
Publicado: (2013)

Innovative delivery systems for epicutaneous immunotherapy
por: Wang, Zhen, et al.
Publicado: (2023)

JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE
por: Cheng, Edaire, et al.
Publicado: (2016)

Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy
por: Wang, Yensheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3a9h9u72spigomrtpe06dq3ct6